MARK FLETCHER Insider Trading $GNBT GENEREX BIOTECHNOLOGY CORP
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MARK FLETCHER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARK FLETCHER. MARK FLETCHER is EVP General Counsel &Secretary in GENEREX BIOTECHNOLOGY CORP ($GNBT) and Executive VP and General Couns in GENEREX BIOTECHNOLOGY CORP ($GNBT) and President & CEO in GENEREX BIOTECHNOLOGY CORP ($GNBT) and See Remarks in GENEREX BIOTECHNOLOGY CORP ($GNBT).
MARK FLETCHER in GENEREX BIOTECHNOLOGY CORP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MARK FLETCHER: EVP General Counsel &Secretary, President & CEO, See Remarks, Executive VP and General Couns
Holdings: 15,821,836 shares
Current Value: $158,218
Latest Transaction: Oct 15 2018
$GNBT Market Capitalization: $10.45M
$GNBT Previous Close: $0.01
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MARK FLETCHER in GENEREX BIOTECHNOLOGY CORP
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 15 2018 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | EVP General Counsel ... | Option Exercise | A | 2.23 | 4,500 | 10,035 | 4,500 | |
| Feb 16 2016 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | President & CEO | Option Exercise | M | 0.00 | 4,447,111 | 4,447 | 0 | |
| Feb 16 2016 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | President & CEO | Buy | M | 0.00 | 4,447,111 | 4,447 | 15,821,836 | 11.4 M to 15.8 M (+39.10 %) |
| Feb 12 2016 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | President & CEO | Option Exercise | M | 0.00 | 4,447,111 | 4,447 | 4,447,111 | |
| Feb 12 2016 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | President & CEO | Option Exercise | M | 0.00 | 1,587,300 | 1,587 | 0 | |
| Feb 12 2016 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | President & CEO | Option Exercise | M | 0.00 | 5,143,787 | 5,144 | 0 | |
| Feb 12 2016 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | President & CEO | Option Exercise | M | 0.00 | 1,457,195 | 1,457 | 0 | |
| Feb 12 2016 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | President & CEO | Buy | M | 0.00 | 14,890,033 | 14,890 | 10,442,992 | -4,447,041 to 10.4 M (-334.83 %) |
| Apr 25 2011 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | See Remarks | Option Exercise | A | 0.28 | 1,500,000 | 423,000 | 1,500,000 | |
| Apr 07 2005 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | Executive VP and Ge ... | Option Exercise | A | 0.00 | 470,726 | 471 | 470,726 | |
| Apr 07 2005 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | Executive VP and Ge ... | Option Exercise | A | 0.61 | 250,000 | 152,500 | 250,000 |
Page: 1